Delivery Order SPE2DB22D2006-SPE2DB25FW0LT
Award Date
4/30/25
Potential Completion Date
5/1/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,809.27, is for the delivery of 4,567,953,384 units of the medication Mycophenolate 500 mg tablets. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Mycophenolate 500 mg tablets. The contract has a ceiling value of $1,287.10 and a performance period extending through April 16, 2025. The award is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,379.40, is for the delivery of 4,564,886 units of the pharmaceutical drug Mycophenolate 500 mg tablets. The contract has a completion date of June 13, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract provides Mycophenolate 500 mg tablets, a prescription medication, to DLA Troop Support Medical facilities supporting the Department of Defense. The firm fixed price contract has a potential value of $3,060.10 and a completion date of February 21, 2024. This delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $1,187.55, is for the delivery of 500 mg mycophenolate tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,857,188 units of the medication Mycophenolate 500 mg tablets, with a ceiling value of $4,891.20. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 10, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MYCOPHENOLATE 500 MG TABLET 500S. The contract, valued at $1,388.16, has a completion date of February 23, 2024. AmerisourceBergen Drug Corp serves as the prime contractor for this order, which is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Mycophenolic Acid DR 360 mg Tablets (120 count). The order has a potential value of $1,660.86 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and the product will be delivered from the company's facilities in Conshohocken, Pennsylvania. This delivery order is part of a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation (Corporate Office Division). The contract is for the supply of Mycophenolic Acid DR 360 mg tablets in quantities of 120 per bottle. The award has a ceiling value of $18,738.53 and is a firm-fixed-price delivery order contract with a period of performance through September 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FB69E, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,294.00 Firm Fixed Price Delivery Order contract is for the supply of 4,567,978,192 units of Mycophenolate 500 mg tablets. The contract has an ultimate completion date of April 22, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00...